PD166326, a novel tyrosine kinase inhibitor, has greater anti-leukemic activity than imatinib in a murine model of chronic myelogenous leukemia Meeting Abstract
| Authors: | Wolff, N. C.; Veach, D. R.; Tong, W. P.; Bornmann, W. G.; Clarkson, B.; Ilaria, R. L. |
| Abstract Title: | PD166326, a novel tyrosine kinase inhibitor, has greater anti-leukemic activity than imatinib in a murine model of chronic myelogenous leukemia |
| Meeting Title: | 45th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 102 |
| Issue: | 11 pt 1 |
| Meeting Dates: | 2003 Dec 6-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2003-11-01 |
| Start Page: | 31A |
| Language: | English |
| ACCESSION: | WOS:000186536700097 |
| PROVIDER: | wos |
| PUBMED: | 14650392 |
| Notes: | Meeting Abstract: 96 -- 45th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2003 -- SAN DIEGO, CALIFORNIA -- 1 -- Source: Wos |
Citation Impact
